Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C M, Phelan"'
Autor:
C M, Phelan, A, Borg, M, Cuny, D N, Crichton, T, Baldersson, T I, Andersen, M A, Caligo, R, Lidereau, A, Lindblom, S, Seitz, D, Kelsell, U, Hamann, P, Rio, S, Thorlacius, J, Papp, E, Olah, B, Ponder, Y J, Bignon, S, Scherneck, R, Barkardottir, A L, Borresen-Dale, J, Eyfjörd, C, Theillet, A M, Thompson, C, Larsson
Publikováno v:
Cancer research. 58(5)
The pattern of loss of heterozygosity (LOH) on chromosome 17 in human breast cancer is complicated and shows many different regions of loss. In an attempt to narrow down the relevant regions of LOH on chromosome 17, we have studied the deletion patte
Autor:
T R, Rebbeck, A H, Walker, C M, Phelan, A K, Godwin, K H, Buetow, J E, Garber, S A, Narod, B L, Weber
Publikováno v:
Progress in clinical and biological research. 396
Most breast cancer has a complex, multifactorial etiology. One consequence of this multifactorial phenomenon is that etiological heterogeneity may exist. This heterogeneity implies simply that two or more groups of breast cancer cases in the general
Autor:
M H, Ruttledge, A A, Andermann, C M, Phelan, J O, Claudio, F Y, Han, N, Chretien, S, Rangaratnam, M, MacCollin, P, Short, D, Parry, V, Michels, V M, Riccardi, R, Weksberg, K, Kitamura, J M, Bradburn, B D, Hall, P, Propping, G A, Rouleau
Publikováno v:
American journal of human genetics. 59(2)
The gene predisposing to neurofibromatosis type 2 (NF2) on human chromosome 22 has revealed a wide variety of different mutations in NF2 individuals. These patients display a marked variability in clinical presentation, ranging from very severe disea